Familial thrombophilia and the prothrombin 20210A mutation
Careful selection of sample dilution and factor-V-deficient plasma makes the modified activated protein C resistance test highly specific for the factor V Leiden mutation
Acute effects of angiotensin II on fibrinolysis in healthy volunteers
Performance of the platelet function analyser PFA-100® in testing abnormalities of primary haemostasis
Treatment with recombinant activated factor VII in a patient with hemophilia A and an inhibitor
The prothrombin 20210A allele and the factor V Leiden are associated with venous thrombosis but not with early coronary artery disease